First Light Asset Management, LLC Mei Pharma, Inc. Transaction History

First Light Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.65 $1.9 Million - $2.94 Million	-4,525,034 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.54 - $2.74 $3.61 Million - $18.3 Million	-6,692,392 Reduced 59.66%	4,525,034 $2.73 Million
Q4 2021 Feb 14, 2022	BUY	$2.33 - $3.37 $6.01 Million - $8.69 Million	2,579,951 Added 29.87%	11,217,426 $30 Million
Q3 2021 Nov 12, 2021	BUY	$2.52 - $2.99 $4.14 Million - $4.91 Million	1,641,768 Added 23.47%	8,637,475 $23.8 Million
Q2 2021 Aug 13, 2021	BUY	$2.6 - $3.65 $1.6 Million - $2.25 Million	616,772 Added 9.67%	6,995,707 $19.9 Million
Q1 2021 May 17, 2021	BUY	$2.73 - $4.5 $7.06 Million - $11.6 Million	2,585,660 Added 68.16%	6,378,935 $21.9 Million
Q4 2020 Feb 16, 2021	BUY	$2.6 - $3.32 $76,624 - $97,843	29,471 Added 0.78%	3,793,275 $10 Million
Q3 2020 Nov 13, 2020	BUY	$2.46 - $4.27 $9.26 Million - $16.1 Million	3,763,804 New	3,763,804 $11.7 Million

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.